Investigation of the effect of breast milk, probiotic supplemented and plain milk formulas on some oral bacteria in infants: an observational and in-vitro study / Investigação do efeito do leite materno, fórmulas de leite puro e suplementado com probióticos sobre algumas bactérias orais em lactentes: um estudo observacional e in vitro

Objetivo: existem evidências inconclusivas sobre a potencial carogenicidade das fórmulas lácteas em comparação com o leite materno. O estudo teve como objetivo comparar a detecção e contagem de Streptococcus mutans(S. mutans) e lactobacilos da saliva entre lactentes alimentados com leite materno (B), com fórmulas de leite puro (France Lait-FL) e suplementada com probióticos (Nan 1 optipro-N), e avaliar crescimento in vitro dessas bactérias em amostras de leite materno e fórmulas lácteas. Material e Métodos: amostras salivares foram obtidas com swabs de algodão estéreis de 60 lactentes que foram agrupados de acordo com o tipo de leite. As amostras foram cultivadas para obter a frequência de detecção e contagens bacterianas. Para a investigação in vitro, sete amostras de leite materno doado e sete amostras recém-preparadas de ambas as fórmulas lácteas foram inoculadas por ambas as bactérias e então cultivadas para avaliar o crescimento bacteriano. Resultados:lactobacilos foram detectados em todos os lactentes, enquanto não foram encontradas diferenças significativas na detecção de S. mutans entre os grupos. As contagens de ambos os microrganismos na saliva foram menores em (B), enquanto uma diferença insignificante foi encontrada entre (B) e (N). Diferenças significativas foram evidentes nas contagens bacterianas in vitro sendo mais baixas em (B) seguido por (N) e (FL). Conclusão: o leite materno e as fórmulas lácteas com suplementos probióticos podem ter um papel protetor contra a cárie dentária em lactentes. (AU)

Objective: inconclusive evidence exists regarding potential cariogenicity of milk formulas compared to breast milk. The study aimed to compare Salivary Streptococcus mutans (S. mutans) and lactobacilli detection and counts among breastfed (B), plain formula (France Lait 1) (FL) and probiotic supplemented formula (Nan 1 optipro) (N) infants and to assess in-vitro growth of these bacteria in breast milk and milk formula samples. Material and Methods:salivary samples were obtained using sterile cotton swabs from 60 infants that were grouped according to nursing milk type. Samples were cultured to obtain the detection frequency and bacterial counts. For the in-vitro investigation, seven donated breast milk samples and seven freshly prepared samples of both milk formulas were inoculated by both bacteria and then cultured to assess bacterial growth. Results:lactobacilli were detected in all infants, while no significant differences were found in S. mutans detection among groups. Counts of both microorganisms in saliva were lowest in (B) while, insignificant difference was found between (B) and (N). Significant differences were evident in in-vitro bacterial counts being lowest in (B) followed by (N) and (FL). Conclusion: breast milk and probiotic supplement infants' milk formulas may have a protective role against dental caries in infants.(AU)

Obesidad en lactantes: efecto protector de la lactancia materna versus fórmulas lácteas / Childhood obesity: the benefits of breastfeeding versus formula feeding

El objetivo del trabajo fue analizar el posible efecto protector de la lactancia materna respecto a la obesidad infantil versus fórmulas lácteas. Se consultaron las bases de datos PubMed, Web of Science y Scielo, considerándose los artículos más actualizados sobre el tema. La evidencia analizada señala que los menores alimentados con lactancia materna exclusiva reportan bajos niveles de sobrepeso y obesidad, a diferencia de los alimentados con fórmulas lácteas infantiles. Se concluye que la lactancia materna exclusiva, hasta el sexto mes de vida del lactante, y complementada con alimentación solida (no láctea) hasta los dos o más años, es recomendada y podría proteger contra la obesidad infantil y sus comorbilidades asociadas en la vida adulta.

The aim was to review the evidence supporting the possible health benefits for obesity of breastfeeding versus formula feeding in infants. The search for studies addressing this topic was conducted in PubMed, Web of Science and Scielo databases. "Breastfeeding", "formula feeding" and "obesity" were the keywords used in the search. Only studies with a full version of the manuscript were included. The evidence analyzed indicated that children fed exclusively through breastfeeding reported low levels of overweight and obesity in comparison to those fed by infant milk formulas. To conclude, exclusive breastfeeding until the sixth month of life, and supplementation with solid (non-dairy) food until two years and more, is the gold standard and could protect against childhood obesity and its associated comorbidities in adult life.

The clinical characteristics and related factors of cow's milk protein allergy in infants less than 3 months old in Guangxi District / 中国小儿急救医学

Objective To study the clinical characteristics and risk factors of cow's milk protein allergy(CMPA)in infants less than 3 months old in Guangxi District.Methods From July 1 ,2012,to December 30,2014,infants less than 3 months old suspected of CMPA visiting the pediatric outpatient depart-ment of Maternal and Children Hospital of Guangxi Zhuang Autonomous Region were recruited,which included initial diagnosis and being transported from peripheral hospitals.Observation scale was formulated, attending physician screened patients and their senior made a definite diagnosis.All the infants underwent diagnostic algorithms and were followed up constantly.Results A total of 137 cases were divided into aller-gy group(n =51 )and control group(n =86).Two groups shared some common symptoms such as diarrhea, constipation,bloody stool,stomachache,gastroesophageal reflux(GER),indigestion,anorexia,feeding diffi-culties.Between the allergy group and control group the parameters such as feeding patterns (including breast feeding,mix feeding,formula feeding),improper deeding of food supplement,long-term use of antibiotics in neonatal period and parental atopy showed no significant differences(P ﹥0.05).The parameters in neonatal period including GER [20 cases (39.2%)vs.7 cases (8.1 %)],intake of cow's milk formula [51 cases (100%)vs.71 cases (82.6%)],feeding intolerance (including GER)[17 cases (33.3%)vs.1 1 cases (12.8%)],gut infection[8 cases(15.7%)vs.4 cases(4.7%)],transfusion of blood or/and bloody prod-ucts[12 cases(23.5%)vs.1 1 cases(12.8%)]showed statistically significant differences between the aller-gy group and control group(χ2 =19.538,P =0.000;χ2 =9.989,P =0.002;χ2 =8.308,P =0.004;χ2 =4.691 ,P =0.030;χ2 =5.198,P =0.023 ).Conclusion Symptoms of CMPA in infants no more than 3 months old involve mainly digestive system such as diarrhea,bloody stool,GER.Intake of cow milk formula in neonatal period play an important role in triggering CMPA.

¿Cuál es el impacto de incorporar probióticos a la leche de fórmula en la salud de lactantes y niños no prematuros?: síntesis rápida de evidencia / What is the impact of incorporating probiotics into formula milk on the health of infants and non premature infants?: rapid evidence synthesis

ANTECEDENTES Y OBJETIVO Dada la amplia diversidad existente de probióticos y las distintas formas y dosis de administración, es esencial conocer en detalle evidencia científica disponible con el objetivo de determinar con claridad los beneficios sanitarios y los potenciales efectos adversos que su administración pudiese generar en la población. En este contexto el Departamento de Nutrición y Alimentos/DIPOL solicitan esta síntesis de evidencia con el objetivo de describir los principales resultados científicos relativos al efecto clínico de la suplementación alimentaria con probióticos, en lactantes y niños no prematuros. METODOLOGÍA Se formuló una estrategia de búsqueda para ser utilizada en 5 bases de datos con el objetivo de identificar revisiones sistemáticas del tema. Se seleccionaron preferentemente las que se realizaron en los últimos 5 años y que abordaban específicamente el impacto directo en la leche de fórmula sobre niños no prematuros. Se incluyeron artículos que consideraban la ingesta de probióticos en general, mientras que se excluyeron los que no tenían como población objetivo a niños o lactantes. RESULTADOS El resumen utiliza 13 revisiones sistemáticas -El uso de probióticos sería beneficioso para el tratamiento y prevención de enfermedades gastrointestinales en infantes y niños, no obstante, no es claro su impacto sobre algunas de estas enfermedades. -Los probióticos tiene un efecto beneficioso en la frecuencia y duración de infecciones agudas respiratorias altas en niños. Sin embargo, los resultados presentan alta heterogeneidad. -La suplementación de la alimentación con probióticos produce una disminución de la incidencia y gravedad de la dermatitis atópica en niños. La evidencia en la prevención de otras enfermedades alérgicas no es clara. -No está claro si hay un efecto significativo en el crecimiento de infantes alimentados con leche de formula suplementada con probióticos. -La escasa evidencia disponible muestra que la suplementación de la alimentación con probióticos no produciría efectos adversos. -Pese al posible efecto que pudiese tener el financiamiento por parte de la industria en la calidad metodológica y efecto clínico de los ensayos clínicos controlados, no existiría una asociación significativa de sesgo de resultados en comparación con estudios financiados con otro tipo de fuentes.

Occurrence and characterization of toxigenic Bacillus cereus in food and infant feces

Objective:To investigate the true incidence of Bacillus cereus (B. cereus) in food and children diarrhea cases. Methods:A total of 110 samples of various dairy products such as raw milk, long life pasteurized milk, yoghurt and infant powdered milk formulas, raw rice, and feces were examined for the presence of B. cereus by selective plating on mannitol-egg-yolk-polymyxin agar. Confirmation of B. cereus was carried out by biochemical tests and PCR. Identification of non-B. cereus isolates was carried out by 16S rDNA sequencing. Antimicrobial susceptibility was done by disk diffusion method. Results:Overall 35 samples (31.8%, n=110) yielded Bacillus-like growth. Of which 19 samples (54.28%) were positive for B. cereus. All isolates were positive for enterotoxin production. No psychrotolerant B. cereus strains were detected in all samples. All B. cereus isolates were resistant to penicillin G, but susceptible to vancomycin, erythromycin and clindamycin. Conclusions:The results of this study confirm the importance of including B. cereus in disease control and prevention programs, as well as in routine clinical and food quality control laboratories in both Saudi Arabia and Egypt.

Occurrence and characterization of toxigenic Bacillus cereus in food and infant feces

Objective: To investigate the true incidence of Bacillus cereus (B. cereus) in food and children diarrhea cases. Methods: A total of 110 samples of various dairy products such as raw milk, long life pasteurized milk, yoghurt and infant powdered milk formulas, raw rice, and feces were examined for the presence of B. cereus by selective plating on mannitol-egg-yolkpolymyxin agar. Confirmation of B. cereus was carried out by biochemical tests and PCR. Identification of non-B. cereus isolates was carried out by 16S rDNA sequencing. Antimicrobial susceptibility was done by disk diffusion method. Results: Overall 35 samples (31.8%, n = 110) yielded Bacillus-like growth. Of which 19 samples (54.28%) were positive for B. cereus. All isolates were positive for enterotoxin production. No psychrotolerant B. cereus strains were detected in all samples. All B. cereus isolates were resistant to penicillin G, but susceptible to vancomycin, erythromycin and clindamycin. Conclusions: The results of this study confirm the importance of including B. cereus in disease control and prevention programs, as well as in routine clinical and food quality control laboratories in both Saudi Arabia and Egypt.

Perfil de triacilgliceroles y porcentaje de ácido palmítico en la posición sn-2 en sustitutos de leche materna / Profile of triacylglycerols and percentage of palmitic acid at the sn-2 in breast milk substitutes

El objetivo del presente trabajo es analizar el porcentaje de ácido palmítico en la posición sn-2 de los triacilgliceroles en sustitutos de la leche materna. Se analizaron 6 productos del mercado argentino que se presentan como sustitutos de la leche materna durante el primer semestre de vida: 2 fórmulas con aceites vegetales como fuente básica de lípidos (F1 y F2); 1 fórmula con grasa láctea como base y aceites vegetales (F3); 1 fórmula con lípidos estructurados y aceites vegetales (F4); 2 fórmulas para prematuros, una con grasa láctea como base y otros aceites (F5) y otra con aceites vegetales (F6). Los resultados muestran que F1, F2, F3 y F4 presentaron 14,6%, 14,8%, 48,1% y 44,5% del ácido palmítico en la posición sn-2, respectivamente. Por su parte, las fórmulas F5 y F6 presentaron 49,5% y 14,6% delácido palmítico en la posición sn-2. Las fórmulas con base láctea presentaron la mayor concentración de ácido palmítico en la posición sn-2.

The aim of this study was to analyze the percentage of palmitic acid at sn-2 position on triacylglycerols in infant formulas. We studied 6 infant formulas in the Argentinean market that are used as breast-milk substitutes during the frst six months after delivery: 2 formulas with vegetable oils as basic source of lipids (F1, F2); 1 formula with milk fat and vegetable oils (F3); 1 formula with structured lipids and vegetable oils (F4); 2 formulas for pre-term infants, one with milk fat and other oils (F5), and the other with vegetable oils (F6). Results showed that F1, F2, F3 and F4 presented 14.6%, 14.8%, 48.1% and 44.5%, respectively, of palmitic acid at sn-2 position, whereas formulas F5 and F6 had 49.5% and 14.6%, respectively, of palmitic acid at sn-2 position. Milk-based infant formulas had the highest concentration of palmitic acid at sn-2 position.